Yohei Hisada

Corrigendum to "Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays" [Thromb. Res. 139 (2016) 90-97].

Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.

Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice.

Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.

Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48].

Detection of tissue factor-positive extracellular vesicles by laser scanning confocal microscopy.

Cancer-associated pathways and biomarkers of venous thrombosis.

Mouse models of cancer-associated thrombosis.

Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.

Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients.

Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.

The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction.

mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.

Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Measurement of tissue factor activity in extracellular vesicles from human plasma samples.

Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors.

Patients with severe orthohantavirus cardiopulmonary syndrome due to Sin Nombre Virus infection have increased circulating extracellular vesicle tissue factor and an activated coagulation system.

Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis.

Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.

Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.

Neutrophil Extracellular Traps: Villains and Targets in Arterial, Venous, and Cancer-Associated Thrombosis.

Rivaroxaban does not affect growth of human pancreatic tumors in mice.

Increasing the sensitivity of the human microvesicle tissue factor activity assay.

Circulating Extracellular Vesicle Tissue Factor Activity During Orthohantavirus Infection Is Associated With Intravascular Coagulation.

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.

Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik).

Chemotherapy Increases Stroke: Fact or Fiction?

Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer.

Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma.

Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting.

Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report.

Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.

The Intrinsic Pathway does not Contribute to Activation of Coagulation in Mice Bearing Human Pancreatic Tumors Expressing Tissue Factor.

Cancer Therapy-Associated Thrombosis.

Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer.

Effects of storage and leukocyte reduction on the concentration and procoagulant activity of extracellular vesicles in canine packed red cells.

Comparison of the coagulopathies associated with COVID-19 and sepsis.

Cell type-specific roles of PAR1 in Coxsackievirus B3 infection.

Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer.

Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies: Comment from Mackman et al.

Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer: Comment by Mackman et al.

Evaluation of a new bead-based assay to measure levels of human tissue factor antigen in extracellular vesicles in plasma.

Therapeutic potential of granulocyte microvesicles in sepsis.

Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases.

Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods.

Circulating Tumor Cells and Cancer-Associated Venous Thrombosis: A Missing Link.

Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer.

Tissue factor activity of small and large extracellular vesicles in different diseases.

Leg skeletal muscle mass asymmetry is independently associated with gait speed in older adults requiring long-term care.

Mechanisms of cancer-associated thrombosis.

Tissue factor-positive extracellular vesicles in plasma are not associated with venous thromboembolism in patients with ovarian cancer.

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study.

International Epidemiology of Carbapenemase-Producing Escherichia coli.

Fatal acute portal vein thrombosis associated with hepatic cysts in a patient with autosomal dominant polycystic kidney disease.

Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modeling.

RNA ligase ribozymes with a small catalytic core.

Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review.

Evaluation of four commercial ELISAs to measure tissue factor in human plasma.

Detection of tissue factor-positive extracellular vesicles using the ExoView R100 system.

Philodulcilactobacillus myokoensis gen. nov., sp. nov., a fructophilic, acidophilic, and agar-phobic lactic acid bacterium isolated from fermented vegetable extracts.

Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.

Merger of Rotation Restriction and Symmetrical Push-Pull to Synthesize Single-Benzene Yellow Fluorophors.

Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.

Significance of programmed death-ligand 1 expression in resected lung cancer and its relationship with EGFR mutation.

Xenograft of human pluripotent stem cell-derived cardiac lineage cells on zebrafish embryo heart.

Adipocyte regulation of cancer stem cells.

Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.

Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment.

Giant Brachial Artery Aneurysm.

Up-Regulated Expression of ICAM1, MT1A, PTGS2, LCE3D, PPARD, and GM-CSF2 Following Solar Skincare Protection and Repair Strategies in a 3-Dimensional Reconstructed Human Skin Model.

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.

Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its role.

CO switchable adhesion of ionic polydimethylsiloxane elastomers.

Efficient selection of knocked-in pluripotent stem cells using a dual cassette cellular elimination system.